Drug Trial Radar · NCT00788229
Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
Last checked: Nov 19, 2026Latest source record: Apr 2, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Nov 2008
Primary completion
Aug 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- Dhp Korea Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 10, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether artificial tears are safe and effective in the treatment of Dry Eye Syndrome.
Conditions
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
Interventions
AT01Drug
eye drop for 12 weeks
AT02Drug
eye drop for 12 weeks
AT03Drug
eye drop for 12 weeks
AT04Drug
eye drop for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tear Break Up Time (TBUT)Time frame: 12weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Asan medical center
Seoul, 388-1 Pungnap-2dong, Songpa-gu, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.